Commercial positioning case studies
Increasing the reach and return on investment in your clinical data with innovative solutions
Learn more about our commercialisation & outcomes expertise in this case study library.
We help pharma, device, and biotechnology companies at every stage of development—from endpoint selection and PRO development, through clinical trials, to post-approval and scientific publication.
Eliminating enrolment delays to bring an AI-enabled SaMD to market
A medical device developer faced clinical evaluation timeline delays due to under-enrolment. Discover how the collaborative partnership between the sponsor and 91黑料’s Medical Device & Diagnostics Research team steered the study from patient enrolment to FDA submission and approval.
Exceeding late phase study recruitment goals
Over 19 days, 91黑料 conducted a focused site engagement programme to increase patient screening and accelerate enrolment of a late phase multinational, multicentre study to evaluate a treatment for pulmonary disease.
Enhancing the impact of scientific posters
The 91黑料 global medical communications group worked with a large pharmaceutical company to identify ways to engage the congress audience and expand the impact of their scientific presentations at a large international meeting.
Post-Marketing Surveillance Studies in Korea
portfolio spanning more than seven automated instruments and more than 500 analytes or assays.
Prioritizing efficiency and fit for purpose strategy in digital risk detection
91黑料 operationalized a hybrid decentralized clinical trial for participants experiencing bothersome Vasomotor Symptoms (VMS).
Voice & speech recognition
91黑料 Outcome Measures found well-validated tools for processing data associated with speech cadence, vocal pitch, and similar measures to evaluate rates of change in neurologic and psychiatric disorders.
Patient cardiac safety
A digital health lead at a large pharmaceutical company came to 91黑料 Outcome Measures to find a wearable that could capture continuous cardiac rhythms and be used to detect QT prolongation.
Language Services: Voiceover and video localisation
91黑料 provided a fully localised and tested informational solution for patients that was consistent across platform components for online materials developed to train patients on the consent process.
Launching into an established market
91黑料 Market Access played a key role in informing a client’s go-to-market strategy, including analytics around market sizing, a competitive landscape assessment and a benefit design analysis for a long-acting, injectable anti-psychotic drug.
Chronic Myeloid Leukaemia
As a result of the multifaceted communication approach with sites and a strong partnership between 91黑料 and sponsor, the study met its protocol-specified enrolment goal just 9 days beyond contracted Last Patient In date (LPI).
Electronic implementation and digital app localisation
91黑料 delivered a multifaceted omnichannel awareness campaign to provide a seamless customer experience between print and digital channels for a drug to treat PPD.
Driving payer education and awareness
91黑料 delivered a multifaceted omnichannel awareness campaign to provide a seamless customer experience between print and digital channels for a drug to treat PPD.